Amplitude Surgical SAS (AMPLI) - Total Assets
Based on the latest financial reports, Amplitude Surgical SAS (AMPLI) holds total assets worth €279.66 Million EUR (≈ $326.96 Million USD) as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Amplitude Surgical SAS shareholders equity for net asset value and shareholders' equity analysis.
Amplitude Surgical SAS - Total Assets Trend (2011–2024)
This chart illustrates how Amplitude Surgical SAS's total assets have evolved over time, based on quarterly financial data.
Amplitude Surgical SAS - Asset Composition Analysis
Current Asset Composition (June 2024)
Amplitude Surgical SAS's total assets of €279.66 Million consist of 33.9% current assets and 66.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €1.99 Million | 10.4% |
| Accounts Receivable | €19.80 Million | 7.1% |
| Inventory | €43.30 Million | 15.5% |
| Property, Plant & Equipment | €41.46 Million | 14.9% |
| Intangible Assets | €37.29 Million | 13.4% |
| Goodwill | €98.80 Million | 35.4% |
Asset Composition Trend (2011–2024)
This chart illustrates how Amplitude Surgical SAS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see AMPLI company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Amplitude Surgical SAS's current assets represent 33.9% of total assets in 2024, an increase from 28.0% in 2011.
- Cash Position: Cash and equivalents constituted 10.4% of total assets in 2024, up from 4.7% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, a decrease from 62.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 35.4% of total assets.
Amplitude Surgical SAS Competitors by Total Assets
Key competitors of Amplitude Surgical SAS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcon AG
SW:ALC
|
Switzerland | CHF31.53 Billion |
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
USA | $32.49 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥993.46 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
Amplitude Surgical SAS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.91 | 2.17 | 2.20 |
| Quick Ratio | 0.94 | 1.21 | 1.06 |
| Cash Ratio | 0.04 | 0.43 | 0.00 |
| Working Capital | €43.56 Million | €50.00 Million | €44.86 Million |
Amplitude Surgical SAS - Advanced Valuation Insights
This section examines the relationship between Amplitude Surgical SAS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.17 |
| Latest Market Cap to Assets Ratio | 1.07 |
| Asset Growth Rate (YoY) | 5.0% |
| Total Assets | €279.25 Million |
| Market Capitalization | $299.85 Million USD |
Valuation Analysis
Above Book Valuation: The market values Amplitude Surgical SAS's assets above their book value (1.07x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Amplitude Surgical SAS's assets grew by 5.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Amplitude Surgical SAS (2011–2024)
The table below shows the annual total assets of Amplitude Surgical SAS from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | €279.25 Million ≈ $326.48 Million |
+4.98% |
| 2023-06-30 | €266.02 Million ≈ $311.00 Million |
+2.53% |
| 2022-06-30 | €259.46 Million ≈ $303.34 Million |
-3.57% |
| 2021-06-30 | €269.07 Million ≈ $314.57 Million |
-2.23% |
| 2020-06-30 | €275.20 Million ≈ $321.74 Million |
-1.69% |
| 2019-06-30 | €279.92 Million ≈ $327.26 Million |
-2.87% |
| 2018-06-30 | €288.20 Million ≈ $336.94 Million |
+6.36% |
| 2017-06-30 | €270.96 Million ≈ $316.78 Million |
+5.32% |
| 2016-06-30 | €257.26 Million ≈ $300.77 Million |
+4.13% |
| 2015-06-30 | €247.07 Million ≈ $288.85 Million |
+41.24% |
| 2014-06-30 | €174.93 Million ≈ $204.51 Million |
+23.79% |
| 2013-06-30 | €141.31 Million ≈ $165.20 Million |
+8.50% |
| 2012-06-30 | €130.24 Million ≈ $152.26 Million |
+4.24% |
| 2011-06-30 | €124.94 Million ≈ $146.07 Million |
-- |
About Amplitude Surgical SAS
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-u… Read more